RE:RE:Denali trading at 35 dollars, bioasis trading at 35 centsI like seeing Denali trading at such a large market cap. To me the biggest diffence between DNLI and BTI is that DNLI is ahead from the perspective of having a few targets at early clincal stage and it is very well funded. It would seem that BTI and BTI partnerships are closing in on reaching early clincal stage for a few compounds. The DNLI market cap shows the potential valuation for BTI once BTI reaches this stage. DrDR has shown she can make good deals and as she makes more deals it will further bring additional deals and funding BTI's way. I think BTI's market cap will then start to take care of itself.